Version Published Changed By Comment
CURRENT (v. 3) Jul 08, 2022 16:29
v. 2 Jun 24, 2022 14:29
v. 1 Jan 18, 2022 14:17

Use Case Description:

Note: This use case is from the American Clinical Laboratory Association (ACLA) to cover the increasing volume in at home specimen collection partially due to EAU approved test that do not require a prescription.  

Patient contacts doctor, concerning symptoms of COVID-19, who orders a test and a test kit is sent by mail to the patient.  Alternately a patient may acquire a test kit on their own (order online or purchase at retail store).  

Patient following the included directions collects specimen and sends to the Laboratory.  

Laboratory personnel perform the test and submit results to the patient, public health if reportable, and to the ordering provider if applicable.  


Ordering Provider (Optional)

Trans Woman Patient

Laboratory Personnel

Scope Statement:

If ordered by the provider, the EHR would present AOE questions and send with the order to the Laboratory but if the patient acquires the test without a provider, then the directions would need to be updated to include AOE questions.  




Alternative and/or related Workflow(s):

Alignment and/or Misalignment with Gender Harmony Model:

Currently recorded gender received in PID-8 is used for billing.  

After Gender Harmony implementation, Preferred Name could be collected for use in mail, email, and text communications.  

Some states want Gender Identity and Sexual Orientation reported but only Gender Identity is in Gender Harmony.  

Current Standard Support:

  • HL7 V2.x   
V2.x Resource: 
  • HL7 V3
V3 Resource:
  • HL7 FHIR
FHIR Resource:
DICOM Resource:
NCPDP Resource:
  • X12
X12 Resource:
  • Other (please specify standard and resource below)


Required Additional Standard Support:

  • No labels